Cantor Fitzgerald reiterates Overweight rating on Ventas stock at $93

Cantor Fitzgerald has reiterated its Overweight rating and $93.00 price target for Ventas (NYSE:VTR) after the healthcare REIT’s strong fourth-quarter 2025 results and positive 2026 outlook. The firm highlighted 15% same-store NOI growth in the Senior Housing Operating Portfolio (SHOP) segment and sees potential for raised forecasts. Despite a positive analyst consensus and consistent dividends, InvestingPro’s Fair Value assessment suggests the stock may be overvalued.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
Add a comment
Add a comment
No comments
  • Pin